Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123174745 | 12317474 | 5 | F | 20160801 | 20160429 | 20160805 | EXP | US-PFIZER INC-2016233760 | PFIZER | 70.00 | YR | M | Y | 0.00000 | 20160805 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123174745 | 12317474 | 1 | PS | VFEND | VORICONAZOLE | 1 | 200 MG, UNK | F10201930 | 21266 | 200 | MG | ||||||||
| 123174745 | 12317474 | 2 | SS | VFEND | VORICONAZOLE | 1 | UNK | F10201930 | 21266 | ||||||||||
| 123174745 | 12317474 | 3 | SS | VFEND | VORICONAZOLE | 1 | 300 MG, 2X/DAY | F10201930 | 21266 | 300 | MG | BID | |||||||
| 123174745 | 12317474 | 4 | C | PREDNISONE. | PREDNISONE | 1 | 5 MG, 1X/DAY(BREAKFAST) | 0 | 5 | MG | QD | ||||||||
| 123174745 | 12317474 | 5 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 1 DF, BEDTIME (SULFAMETHOXAZOLE 400MG, TRIMETHOPRIM 80MG, MON,WED, AND FRI. ONLY) | 0 | 1 | DF | TABLET | ||||||||
| 123174745 | 12317474 | 6 | C | SEPTRA | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 1 DF, BEDTIME (SULFAMETHOXAZOLE 400MG, TRIMETHOPRIM 80MG, MON,WED, AND FRI. ONLY) | 0 | 1 | DF | TABLET | ||||||||
| 123174745 | 12317474 | 7 | C | TACROLIMUS. | TACROLIMUS | 1 | 1 MG. (1.5 MG), 2X/DAY(BREAKFAST, BEDTIME) | 0 | 1.5 | MG | BID | ||||||||
| 123174745 | 12317474 | 8 | C | CLONIDINE. | CLONIDINE | 1 | 1 MG, 1/2 IN A.M., 1 IN P.M. | 0 | BID | ||||||||||
| 123174745 | 12317474 | 9 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 123174745 | 12317474 | 10 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 123174745 | 12317474 | 11 | C | NOXAFIL | POSACONAZOLE | 1 | 300 MG, 1X/DAY | 0 | 300 | MG | TABLET | QD | |||||||
| 123174745 | 12317474 | 12 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | 250 MG, MON, WED, AND FRI. ONLY | 0 | 250 | MG | |||||||||
| 123174745 | 12317474 | 13 | C | PEPCID | FAMOTIDINE | 1 | 20 MG, 1X/DAY(BREAKFAST) | 0 | 20 | MG | QD | ||||||||
| 123174745 | 12317474 | 14 | C | IRON SULFATE | FERROUS SULFATE ANHYDROUS | 1 | 325 MG, 1X/DAY(BREAKFAST) | 0 | 325 | MG | QD | ||||||||
| 123174745 | 12317474 | 15 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 10 MG, 1X/DAY (BEDTIME) | 0 | 10 | MG | QD | ||||||||
| 123174745 | 12317474 | 16 | C | ASPRIN | ASPIRIN | 1 | 81 MG, 1X/DAY(BREAKFAST) | 0 | 81 | MG | QD | ||||||||
| 123174745 | 12317474 | 17 | C | LASIX | FUROSEMIDE | 1 | 140 MG, DAILY (80 MG IN A.M. 60 MG IN P.M.) | 0 | 140 | MG | |||||||||
| 123174745 | 12317474 | 18 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK, 2X/DAY (FLUTICASONE PROPIONATE-250, SALMETEROL XINAFOATE-50, BREAKFAST, BEDTIME) | 0 | BID | ||||||||||
| 123174745 | 12317474 | 19 | C | COQ 10 | UBIDECARENONE | 1 | 200 MG, 1X/DAY(BREAKFAST) | 0 | 200 | MG | QD | ||||||||
| 123174745 | 12317474 | 20 | C | FISH OIL W/OMEGA-3 FATTY ACIDS | FISH OILOMEGA-3 FATTY ACIDS | 1 | 1000 MG, 1X/DAY(BREAKFAST) | 0 | 1000 | MG | QD | ||||||||
| 123174745 | 12317474 | 21 | C | CALCIUM +D3 | CALCIUMCHOLECALCIFEROL | 1 | 1 DF, DAILY (CALCIUM 600+ D3; 1 DAILY 2 ON M, W, F, BREAKFAST) | 0 | 1 | DF | |||||||||
| 123174745 | 12317474 | 22 | C | RENA-VITE | ASCORBIC ACIDBIOTINCALCIUM PANTOTHENATECYANOCOBALAMINFOLIC ACIDNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVINTHIAMINE MONONITRATE | 1 | UNK, 1X/DAY(BREAKFAST) | 0 | TABLET | QD | |||||||||
| 123174745 | 12317474 | 23 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Sublingual | 1000 UG, 1X/DAY(BREAKFAST) | 0 | 1000 | UG | SUBLINGUAL TABLET | QD | ||||||
| 123174745 | 12317474 | 24 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 20 MG, 1X/DAY(BREAKFAST) | 0 | 20 | MG | TABLET | QD | |||||||
| 123174745 | 12317474 | 25 | C | CALCITRIOL. | CALCITRIOL | 1 | UNK, ALTERNATE DAY, (0.25 AND 0.5 MCG, BREAKFAST) | 0 | QOD | ||||||||||
| 123174745 | 12317474 | 26 | C | PROLIA | DENOSUMAB | 1 | UNK, (EVERY 6 MOS. BREAKFAST) | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123174745 | 12317474 | 1 | Infection |
| 123174745 | 12317474 | 2 | Antifungal treatment |
| 123174745 | 12317474 | 3 | Fungal infection |
| 123174745 | 12317474 | 4 | Transplant rejection |
| 123174745 | 12317474 | 5 | Transplant rejection |
| 123174745 | 12317474 | 6 | Transplant rejection |
| 123174745 | 12317474 | 7 | Transplant rejection |
| 123174745 | 12317474 | 8 | Hypertension |
| 123174745 | 12317474 | 9 | Diabetes mellitus |
| 123174745 | 12317474 | 10 | Blood cholesterol |
| 123174745 | 12317474 | 11 | Anti-infective therapy |
| 123174745 | 12317474 | 12 | Anti-infective therapy |
| 123174745 | 12317474 | 13 | Ulcer |
| 123174745 | 12317474 | 19 | Vitamin supplementation |
| 123174745 | 12317474 | 20 | Vitamin supplementation |
| 123174745 | 12317474 | 21 | Vitamin supplementation |
| 123174745 | 12317474 | 22 | Vitamin supplementation |
| 123174745 | 12317474 | 23 | Vitamin supplementation |
| 123174745 | 12317474 | 24 | Vitamin supplementation |
| 123174745 | 12317474 | 25 | Vitamin supplementation |
| 123174745 | 12317474 | 26 | Bone disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123174745 | 12317474 | OT |
| 123174745 | 12317474 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123174745 | 12317474 | Bacterial test positive | |
| 123174745 | 12317474 | Drug ineffective | |
| 123174745 | 12317474 | Pulmonary mycosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123174745 | 12317474 | 3 | 201306 | 201605 | 0 |